The FDA HRT Decision was Irregular. Why Didn’t Anyone Notice

In the 2026 analysis of the research and media coverage of hormone therapy for menopause (HRT) regarding breast cancer, Health Affairs criticized the lack of nuance on the part of the media, the FDA, and so-called experts, and praised NCHR‘s Diana Zuckerman for pointing out that “claims about hormone therapy’s broad benefits were inconsistent with years of research and would harm millions of women. Zuckerman’s concern is an important reminder that there have always been clinicians, researchers, and patients who have resisted an either/or approach to HRT.”

Read More »

How West Virginia Became the Front Line of the Vaccine Wars

October 8, 2026: Rolling Stone’s comprehensive article explains how West Virginia has become the front line of the vaccine wars. The article shows how the state’s law is being challenged with help from RFK Jr’s lawyer friend Aaron Siri, and cites the statement of Dr. Diana Zuckerman who was vetted by Siri’s law firm for the national vaccine Advisory Committee.

Read More »

Device firms back latest MDUFA deal, while patients want more postmarket safety

MedTech Dive, August 10, 2026: MedTech Dive describes MDUFA Commitment letter for medical device user fees and public FDA meeting. The article quotes CDRH as happy with collaboration, AdvaMed (medical device industry) happy with the decisions, and Diana Zuckerman and other patient and consumer advocates wanting more evidence of safety and effectiveness for all medical devices.

Read More »